Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Blood transfusion <strong>safety</strong> <strong>in</strong> France: develop<strong>in</strong>g tools to support <strong>patient</strong>s<br />
» Laboratoire Français du Fractionnement et des Biotechnologies, a biopharmaceutical<br />
manufactur<strong>in</strong>g company that is <strong>in</strong> charge of blood plasma fractionation; and<br />
» the AFSSAPS, responsible for evaluat<strong>in</strong>g and manag<strong>in</strong>g the security, quality and<br />
efficacy of <strong>health</strong> <strong>care</strong> products.<br />
The Institute National de la Transfusion Sangu<strong>in</strong>e [National Institute of Blood<br />
Transfusion] web site provides a description of other important actors <strong>in</strong> the blood<br />
transfusion field, along with further <strong>in</strong>formation (4).<br />
Current transfusion data and blood transfusion procedures<br />
The three ma<strong>in</strong> groups of pathologies that give rise to transfusion are haemato-oncology<br />
(52.7% of prescriptions), surgical procedures (23.99%) and <strong>in</strong>tensive <strong>care</strong> and medic<strong>in</strong>e<br />
procedures (21.92%) (5). In 2009, 2 979 117 LBPs were distributed − 79% red blood<br />
cells, 9% platelets and 12% plasma – with almost all be<strong>in</strong>g homologous products.<br />
The number of transfused <strong>patient</strong>s has <strong>in</strong>creased s<strong>in</strong>ce 2006 (6). Accord<strong>in</strong>g to the<br />
AFSSAPS, the number of donors rose to 1 773 374 <strong>in</strong> 2009 (1.7 donations per donor),<br />
represent<strong>in</strong>g 4.1% of the population, with equal gender representation. The number of<br />
transfused <strong>patient</strong>s was estimated at 538 506 (52% women, 48% men), with a ratio of<br />
transfused <strong>patient</strong>s of 8.3 per 1000 <strong>in</strong>habitants, although it varied greatly with age (Fig.<br />
4.2).<br />
Fig . 4 .2 . Transfused <strong>patient</strong>s by age and gender, 2011<br />
90 000<br />
75 000<br />
60 000<br />
45 000<br />
30 000<br />
15 000<br />
0<br />
Number of <strong>patient</strong>s Sex ratio M/F<br />
1.8<br />
1.6<br />
1.4<br />
1.2<br />
1.0<br />
0.8<br />
0.6<br />
0.4<br />
0.2<br />
0.0<br />
Less than 28 days<br />
Source: AFSSAPS (6).<br />
29 days to less than 1 year<br />
1–4 years<br />
5–9 years<br />
10–14 years<br />
15–19 years<br />
20–24 years<br />
25–29 years<br />
30–34 years<br />
35–39 years<br />
10–44 years<br />
45–49 years<br />
50–54 years<br />
55–59 years<br />
60–64 years<br />
65–69 years<br />
70–74 years<br />
75–79 years<br />
80–84 years<br />
85–89 years<br />
Over 90 years<br />
Sex ratio<br />
M/F<br />
Male<br />
Female<br />
The generic steps cover<strong>in</strong>g the transfusion procedure are presented <strong>in</strong> Fig. 4.3, along<br />
with the entry po<strong>in</strong>ts for provision of <strong>patient</strong> <strong>in</strong>formation. These appear to relate ma<strong>in</strong>ly<br />
to <strong>in</strong>formed consent and post-transfusion <strong>in</strong>formation.<br />
49